Scott White - Hyperfine Chief Officer

HYPR Stock  USD 0.99  0.02  2.06%   

Insider

Scott White is Chief Officer of Hyperfine
Age 50
Address 351 New Whitfield Street, Guilford, CT, United States, 06437
Phone866 796 6767
Webhttps://hyperfine.io

Hyperfine Management Efficiency

The company has return on total asset (ROA) of (0.3196) % which means that it has lost $0.3196 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5393) %, meaning that it created substantial loss on money invested by shareholders. Hyperfine's management efficiency ratios could be used to measure how well Hyperfine manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/27/2025, Return On Tangible Assets is likely to drop to -0.44. In addition to that, Return On Capital Employed is likely to drop to -0.53. At this time, Hyperfine's Total Assets are relatively stable compared to the past year. As of 02/27/2025, Net Tangible Assets is likely to grow to about 149.4 M, while Non Currrent Assets Other are likely to drop slightly above 1.8 M.
Hyperfine currently holds 185 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Hyperfine has a current ratio of 14.72, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Hyperfine's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Brian MDPAVmed Inc
60
BA ChemistryOrthofix Medical
63
Chi NguyenNeuropace
47
Martha MorrellNeuropace
67
Christopher HollandElectromed
55
Agnes LeeInogen Inc
N/A
Nabil ShabshabInogen Inc
59
Matthew PigeonInogen Inc
N/A
John GlennIradimed Co
63
Mark QuickOrthofix Medical
N/A
Mark SaxtonNeuropace
59
George ParrInogen Inc
53
McAlister MarshallInteger Holdings Corp
51
Adrian MillerPAVmed Inc
N/A
John McKunePulmonx Corp
49
Ehab EsmailOrthofix Medical
53
Kristin CaltriderInogen Inc
56
Michael HutchinsonLivaNova PLC
54
Alex ShvartsburgLivaNova PLC
54
Bart BracyAnika Therapeutics
N/A
Charles IIIAnika Therapeutics
N/A
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. The company was incorporated in 2014 and is based in Guilford, Connecticut. Hyperfine operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 186 people. Hyperfine (HYPR) is traded on NASDAQ Exchange in USA. It is located in 351 New Whitfield Street, Guilford, CT, United States, 06437 and employs 131 people. Hyperfine is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Hyperfine Leadership Team

Elected by the shareholders, the Hyperfine's board of directors comprises two types of representatives: Hyperfine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hyperfine. The board's role is to monitor Hyperfine's management team and ensure that shareholders' interests are well served. Hyperfine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hyperfine's outside directors are responsible for providing unbiased perspectives on the board's policies.
Scott White, Chief Officer
Neela Paykel, Gen Officer
Alok Gupta, Chief Officer
Thomas Teisseyre, Chief Officer
Dave Castiglioni, Chief Officer
Maria Sainz, President CEO
Brett Hale, CFO, Officer
Edmond MD, Chief Officer
Mark Hughes, VP Operations
Jonathan Rothberg, Founder Chairman
Khan MD, Chief Officer
Kyla JD, Chief Officer
MD FACR, Vice Affairs
Tom Teisseyre, Chief Officer

Hyperfine Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hyperfine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Additional Tools for Hyperfine Stock Analysis

When running Hyperfine's price analysis, check to measure Hyperfine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hyperfine is operating at the current time. Most of Hyperfine's value examination focuses on studying past and present price action to predict the probability of Hyperfine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hyperfine's price. Additionally, you may evaluate how the addition of Hyperfine to your portfolios can decrease your overall portfolio volatility.